{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:23:38Z","timestamp":1793766218965,"version":"4.6.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.drudis.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T02:51:21Z","timestamp":1652237481000},"page":"2342-2352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["APJ\/apelin: A promising target for the treatment of retinopathy of prematurity"],"prefix":"10.1016","volume":"27","author":[{"given":"Jingtian","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthil Arun","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.clp.2013.02.001","article-title":"Retinopathy of prematurity-incidence today","volume":"40","author":"Zin","year":"2013","journal-title":"Clin Perinatol"},{"issue":"4","key":"10.1016\/j.drudis.2022.05.004_b0010","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000330174","article-title":"Understanding retinopathy of prematurity: update on pathogenesis","volume":"100","author":"Rivera","year":"2011","journal-title":"Neonatology"},{"issue":"4","key":"10.1016\/j.drudis.2022.05.004_b0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000444901","article-title":"Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology","volume":"109","author":"Cayabyab","year":"2016","journal-title":"Neonatology"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41390-019-0598-y","article-title":"Short- and long-term impact of hyperoxia on the blood and retinal cells' transcriptome in a mouse model of oxygen-induced retinopathy","volume":"87","author":"Zasada","year":"2020","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.drudis.2022.05.004_b0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4161\/org.4.4.7414","article-title":"VEGF and endothelial guidance in angiogenic sprouting","volume":"4","author":"Gerhardt","year":"2014","journal-title":"Organogenesis"},{"key":"10.1016\/j.drudis.2022.05.004_b0030","doi-asserted-by":"crossref","unstructured":"Adair TH, Montani J-P. Angiogenesis. Colloquium Series on Integrated Systems Physiology: From Molecule to Function. 2010\/01\/01 2010;2(1):1-84. doi:10.4199\/C00017ED1V01Y201009ISP010.","DOI":"10.4199\/C00017ED1V01Y201009ISP010"},{"issue":"26","key":"10.1016\/j.drudis.2022.05.004_b0035","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.18043\/ncm.78.2.124","article-title":"Retinopathy of Prematurity","volume":"78","author":"Bashinsky","year":"2017","journal-title":"North Carolina Med J"},{"issue":"9902","key":"10.1016\/j.drudis.2022.05.004_b0045","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0140-6736(13)60178-6","article-title":"Retinopathy of prematurity","volume":"382","author":"Hellstr\u00f6m","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.drudis.2022.05.004_b0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1084-2756(03)00119-2","article-title":"Pathogenesis of retinopathy of prematurity","volume":"8","author":"Smith","year":"2003","journal-title":"Semin Neonatol"},{"issue":"9","key":"10.1016\/j.drudis.2022.05.004_b0055","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1172\/JCI42142","article-title":"Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life","volume":"120","author":"Sapieha","year":"2010","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.earlhumdev.2007.11.008","article-title":"Pathogenesis of retinopathy of prematurity and possible preventive strategies","volume":"84","author":"Fleck","year":"2008","journal-title":"Early Hum Dev"},{"issue":"6","key":"10.1016\/j.drudis.2022.05.004_b0065","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1111\/aos.13297","article-title":"Vascular endothelial growth factor and apelin in plasma of patients with retinopathy of prematurity","volume":"95","author":"Feng","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.drudis.2022.05.004_b0070","doi-asserted-by":"crossref","unstructured":"Heckmann M. [Pathogenesis of retinopathy of prematurity]. Ophthalmologe. Dec 2008;105(12):1101-7. Pathogenese der Retinopathia praematurorum. doi:10.1007\/s00347-008-1789-9.","DOI":"10.1007\/s00347-008-1789-9"},{"issue":"8","key":"10.1016\/j.drudis.2022.05.004_b0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1167\/iovs.61.8.47","article-title":"The Role of Apelin\/APJ in a Mouse Model of Oxygen-induced Retinopathy","volume":"61","author":"Feng","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.drudis.2022.05.004_b0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2147\/EB.S94449","article-title":"Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy","volume":"8","author":"Wang","year":"2016","journal-title":"Eye Brain"},{"issue":"8","key":"10.1016\/j.drudis.2022.05.004_b0085","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.drudis.2022.05.004_b0090","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.108.174847","article-title":"Apelin-APJ signaling in retinal angiogenesis","volume":"28","author":"Kojima","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jcp.27047","article-title":"Targeting drugs to APJ receptor: From signaling to pathophysiological effects","volume":"234","author":"Huang","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.drudis.2022.05.004_b0100","doi-asserted-by":"crossref","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.drudis.2022.05.004_b0105","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1002\/jcp.27942","article-title":"Apelin\/APJ system: A potential therapeutic target for endothelial dysfunction-related diseases","volume":"234","author":"Cheng","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.drudis.2022.05.004_b0110","doi-asserted-by":"crossref","unstructured":"Yuji Kawamata YH, Shoji Fukusumi. Molecular properties of apelin- tissue distribution and receptor binding 2001.","DOI":"10.1016\/S0167-4889(00)00143-9"},{"issue":"8","key":"10.1016\/j.drudis.2022.05.004_b0115","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1167\/iovs.09-4466","article-title":"Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy","volume":"51","author":"Tao","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"28","key":"10.1016\/j.drudis.2022.05.004_b0120","doi-asserted-by":"crossref","first-page":"21061","DOI":"10.1074\/jbc.M908417199","article-title":"Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin","volume":"275","author":"Hosoya","year":"2000","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.drudis.2022.05.004_b0125","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/abbs\/gmt085","article-title":"Jagged-1\/Notch3 signaling transduction pathway is involved in apelin-13-induced vascular smooth muscle cells proliferation","volume":"45","author":"Li","year":"2013","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"9","key":"10.1016\/j.drudis.2022.05.004_b0130","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1096\/fj.05-5243fje","article-title":"TNFalpha up-regulates apelin expression in human and mouse adipose tissue","volume":"20","author":"Daviaud","year":"2006","journal-title":"FASEB J"},{"issue":"12","key":"10.1016\/j.drudis.2022.05.004_b0135","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/abbs\/gmv111","article-title":"Apelin-13 promotes cardiomyocyte hypertrophy via PI3K-Akt-ERK1\/2-p70S6K and PI3K-induced autophagy","volume":"47","author":"Xie","year":"2015","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.drudis.2022.05.004_b0140","doi-asserted-by":"crossref","unstructured":"S. P. Vasculogenesis and angiogenesis. Cancer Treat Res. 2004:117:3-32. doi:10.1007\/978-1-4419-8871-3_1.","DOI":"10.1007\/978-1-4419-8871-3_1"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cardiores.2007.02.002","article-title":"Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice","volume":"74","author":"Zhong","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"Pt B","key":"10.1016\/j.drudis.2022.05.004_b0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cca.2015.09.029","article-title":"Apelin\/APJ signaling in hypoxia-related diseases","volume":"451","author":"He","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0155","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jb\/mvs071","article-title":"Biology of the apelin-APJ axis in vascular formation","volume":"152","author":"Kidoya","year":"2012","journal-title":"J Biochem"},{"key":"10.1016\/j.drudis.2022.05.004_b0160","doi-asserted-by":"crossref","unstructured":"Galanth C. Apelin in the Control of Body Fluid Homeostasis and Cardiovascular Functions 2012.","DOI":"10.2174\/138161212799277770"},{"issue":"4","key":"10.1016\/j.drudis.2022.05.004_b0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/aps.2015.145","article-title":"Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases","volume":"37","author":"Liu","year":"2016","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","article-title":"Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells","volume":"118","author":"Kleinz","year":"2004","journal-title":"Regul Pept"},{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0175","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bbrc.2004.10.042","article-title":"Apelin is a novel angiogenic factor in retinal endothelial cells","volume":"325","author":"Kasai","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.drudis.2022.05.004_b0180","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1242\/dev.072330","article-title":"A role for endothelial cells in promoting the maturation of astrocytes through the apelin\/APJ system in mice","volume":"139","author":"Sakimoto","year":"2012","journal-title":"Development"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0185","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.actbio.2007.12.011","article-title":"Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells","volume":"4","author":"Shen","year":"2008","journal-title":"Acta Biomater"},{"issue":"6","key":"10.1016\/j.drudis.2022.05.004_b0190","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170684","article-title":"The mechanism of all-trans retinoic acid in the regulation of apelin expression in vascular endothelial cells","volume":"37","author":"Shi","year":"2017","journal-title":"Biosci Rep."},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0195","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.emboj.7601982","article-title":"Spatial and temporal role of the apelin\/APJ system in the caliber size regulation of blood vessels during angiogenesis","volume":"27","author":"Kidoya","year":"2008","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0200","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ydbio.2006.04.452","article-title":"Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo","volume":"296","author":"Cox","year":"2006","journal-title":"Dev Biol"},{"key":"10.1016\/j.drudis.2022.05.004_b0205","article-title":"Abdulbaki Karaoglu, K\u00fcrsat Fidanc, Turan Tunc, Secil Aydinoz, Ferhan Karademir & Selami S\u00fcleymanoglu. Correlation between cord blood apelin and IGF-1 levels in retinopathy of prematurity","author":"Ferhat Cekmez","year":"2012","journal-title":"Biomarkers Med"},{"issue":"6","key":"10.1016\/j.drudis.2022.05.004_b0210","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2217\/bmm.12.82","article-title":"Correlation between cord blood apelin and IGF-1 levels in retinopathy of prematurity","volume":"6","author":"Cekmez","year":"2012","journal-title":"Biomarkers Med"},{"issue":"4","key":"10.1016\/j.drudis.2022.05.004_b0215","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/CIRCRESAHA.108.179333","article-title":"Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis","volume":"103","author":"Eyries","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.drudis.2022.05.004_b0220","doi-asserted-by":"crossref","unstructured":"Zelzer E LY, Kahana C, Shilo BZ, Rubinstein M, Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha\/ARNT 1998.","DOI":"10.1093\/emboj\/17.17.5085"},{"issue":"12","key":"10.1016\/j.drudis.2022.05.004_b0225","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1096\/fj.07-104018","article-title":"Apelin\/APJ signaling system: a potential link between adipose tissue and endothelial angiogenic processes","volume":"22","author":"Kunduzova","year":"2008","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.drudis.2022.05.004_b0230","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3892\/mmr.2014.1984","article-title":"Apelin-13 stimulates angiogenesis by promoting crosstalk between AMP-activated protein kinase and Akt signaling in myocardial microvascular endothelial cells","volume":"9","author":"Yang","year":"2014","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0235","first-page":"222","article-title":"Reduced Severity of Oxygen-Induced Retinopathy in eNOS-Deficient Mice","volume":"42","author":"Brooks","year":"2001","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"10","key":"10.1016\/j.drudis.2022.05.004_b0240","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.108.174847","article-title":"Apelin-APJ Signaling in Retinal Angiogenesis","volume":"28","author":"Kojima","year":"2008","journal-title":"Arteriosclerosis Thrombosis Vasc Biol"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0245","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0925-4773(01)00558-5","article-title":"Expression of the murine msr\/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels","volume":"110","author":"Saint-Geniez","year":"2002","journal-title":"Mech Develop"},{"issue":"9","key":"10.1016\/j.drudis.2022.05.004_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202436","article-title":"Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization","volume":"13","author":"McAnally","year":"2018","journal-title":"PloS one"},{"key":"10.1016\/j.drudis.2022.05.004_b0255","doi-asserted-by":"crossref","unstructured":"Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR, O\u2019Dowd BF. Modification of the Terminal Residue of Apelin-13 Antagonizes Its Hypotensive Action. Endocrinology. 2005-01-01 2005;146(1):231-236. doi:10.1210\/en.2004-0359.","DOI":"10.1210\/en.2004-0359"},{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0260","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jhep.2008.09.019","article-title":"Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension","volume":"50","author":"Tiam","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.drudis.2022.05.004_b0265","doi-asserted-by":"crossref","unstructured":"Lu Q, Feng J, Jiang Y-r. The Role of Apelin in the Retina of Diabetic Rats. Plos One 2013;8(7)e69703. doi: 10.1371\/journal.pone.0069703.","DOI":"10.1371\/journal.pone.0069703"},{"key":"10.1016\/j.drudis.2022.05.004_b0270","doi-asserted-by":"crossref","unstructured":"Berta J, Hoda MA, Laszlo V, et al. Apelin promotes lymphangiogenesis and lymph node metastasis. Oncotarget. 2014-06-30 2014;5(12):4426-4437. doi:10.18632\/oncotarget.2032.","DOI":"10.18632\/oncotarget.2032"},{"issue":"10","key":"10.1016\/j.drudis.2022.05.004_b0275","first-page":"5313","article-title":"The Apelin-APJ System Induces Tumor Arteriogenesis in Hepatocellular Carcinoma","volume":"34","author":"Muto","year":"2014","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0280","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ejca.2013.11.017","article-title":"Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas","volume":"50","author":"Picault","year":"2014","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.drudis.2022.05.004_b0285","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00535-014-0992-5","article-title":"Blockade of the apelin\u2013APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy","volume":"50","author":"Yoshiya","year":"2015","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.drudis.2022.05.004_b0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2020.11.017","article-title":"Inhibition of endoplasmic reticulum stress mediates the ameliorative effect of apelin on vascular calcification","volume":"152","author":"Li","year":"2020","journal-title":"J Mol Cellular Cardiol"},{"key":"10.1016\/j.drudis.2022.05.004_b0295","doi-asserted-by":"crossref","unstructured":"Mughal A, Anto S, Sun C, O'Rourke ST. Apelin inhibits an endothelium-derived hyperpolarizing factor-like pathway in rat cerebral arteries. Peptides 2020;132170350. doi: 10.1016\/j.peptides.2020.170350.","DOI":"10.1016\/j.peptides.2020.170350"},{"issue":"12","key":"10.1016\/j.drudis.2022.05.004_b0300","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/1440-1681.13381","article-title":"Central interaction between the apelinergic and vasopressinergic systems in the regulation of the haemodynamic parameters in rats maintained on a high-fat diet","volume":"47","author":"Wojno","year":"2020","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"8","key":"10.1016\/j.drudis.2022.05.004_b0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1167\/iovs.61.8.47","article-title":"The Role of Apelin\/APJ in a Mouse Model of Oxygen-induced Retinopathy","volume":"61","author":"Feng","year":"2020","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0042-6822(02)00021-1","article-title":"Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor","volume":"307","author":"Zhou","year":"2003","journal-title":"APJ Virol"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0315","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0042-6822(03)00185-5","article-title":"Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1","volume":"312","author":"Zhou","year":"2003","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.drudis.2022.05.004_b0320","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/08892220151126508","article-title":"Safe use of the CXCR4 inhibitor ALX40-4C in humans","volume":"17","author":"Doranz","year":"2001","journal-title":"Aids Res Hum Retroviruses"},{"issue":"6","key":"10.1016\/j.drudis.2022.05.004_b0325","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/cmdc.201100069","article-title":"Discovery of a Competitive Apelin Receptor (APJ) Antagonist","volume":"6","author":"Macaluso","year":"2011","journal-title":"ChemMedChem"},{"issue":"4","key":"10.1016\/j.drudis.2022.05.004_b0330","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.gastro.2013.01.004","article-title":"The intestinal glucose-apelin cycle controls carbohydrate absorption in mice","volume":"144","author":"Dray","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2022.05.004_b0335","doi-asserted-by":"crossref","unstructured":"ElizabethHarford-Wright, GwennanAndre-Gregoire, AJacobs K, et al. Pharmacological targeting of apelin impairs glioblastoma growth. Brain: A journal of neurology. 2017;140(11):2939\u201354.","DOI":"10.1093\/brain\/awx253"},{"issue":"6","key":"10.1016\/j.drudis.2022.05.004_b0340","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1096\/fj.201601074R","article-title":"Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin","volume":"31","author":"Le Gonidec","year":"2017","journal-title":"FASEB J"},{"issue":"21","key":"10.1016\/j.drudis.2022.05.004_b0345","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.bmcl.2012.08.105","article-title":"Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor","volume":"22","author":"Maloney","year":"2012","journal-title":"Bioorgan Med Chem Lett"},{"key":"10.1016\/j.drudis.2022.05.004_b0350","doi-asserted-by":"crossref","unstructured":"Roche J, Rame C, Reverchon M, et al. Apelin (APLN) and Apelin Receptor (APLNR) in Human Ovary: Expression, Signaling, and Regulation of Steroidogenesis in Primary Human Luteinized Granulosa Cells. Biol Reprod 2016-11-17 2016;95(5):104-104. doi:10.1095\/biolreprod.116.141754.","DOI":"10.1095\/biolreprod.116.141754"},{"key":"10.1016\/j.drudis.2022.05.004_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.theriogenology.2017.04.014","article-title":"Expression of apelin and apelin receptor (APJ) in porcine ovarian follicles and in vitro effect of apelin on steroidogenesis and proliferation through APJ activation and different signaling pathways","volume":"96","author":"Rak","year":"2017","journal-title":"Theriogenology"},{"key":"10.1016\/j.drudis.2022.05.004_b0360","doi-asserted-by":"crossref","unstructured":"Ishimaru Y, Shibagaki F, Yamamuro A, Yoshioka Y, Maeda S. An apelin receptor antagonist prevents pathological retinal angiogenesis with ischemic retinopathy in mice. Sci Rep 2017-12-01 2017;7(1)doi:10.1038\/s41598-017-15602-3.","DOI":"10.1038\/s41598-017-15602-3"},{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0365","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3892\/mmr.2017.6734","article-title":"Effect of the spinal apelin-APJ system on the pathogenesis of chronic constriction injury-induced neuropathic pain in rats","volume":"16","author":"Xiong","year":"2017","journal-title":"Mol Med Rep"},{"issue":"18","key":"10.1016\/j.drudis.2022.05.004_b0370","article-title":"APLN promotes hepatocellular carcinoma through activating PI3K\/Akt pathway and is a druggable target","volume":"9","author":"Huarong","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0375","article-title":"Melatonin prevents lung injury by regulating apelin 13 to improve mitochondrial dysfunction","volume":"51","author":"Zhang","year":"2019","journal-title":"Exp Mol Med"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0380","article-title":"[Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat]","volume":"38","author":"Zhen-Gui","year":"2013","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chinese materia medica"},{"issue":"24","key":"10.1016\/j.drudis.2022.05.004_b0385","article-title":"[Effects of puerarin on expression of apelin and its receptor of 2K1C renal hypertension rats]","volume":"34","author":"Ge","year":"2009","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0390","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax7379","article-title":"Structure-guided discovery of a single-domain antibody agonist against human apelin receptor","volume":"6","author":"Ma","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2022.05.004_b0395","unstructured":"Lu S-C, Wang M, inventors; Apelin antigen-binding proteins and uses thereof. patent US9156911."},{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0400","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.drudis.2022.05.004_b0405","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2016.12.023","article-title":"Apelin\/APJ system: A novel promising therapy target for pathological angiogenesis. Review","volume":"466","author":"Wu","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.drudis.2022.05.004_b0410","unstructured":"Stevis, Panayiotis, Gromada, et al, inventors; APLNR modulators and uses thereof. patent AU2014352962."},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0415","article-title":"New structural insights into the apelin receptor: identification of key residues for apelin binding","volume":"29","author":"Romain","year":"2015","journal-title":"FASEB J Off Public Feder Am Soc Exp Biol"},{"key":"10.1016\/j.drudis.2022.05.004_b0420","unstructured":"Penninger, Josef, Uribesalgo, Iris, inventors; Combination of An Apelin Antagonist and an Angiogenesis Inhibitor for the Treatment of Cancer. patent WO2017174758."},{"issue":"2","key":"10.1016\/j.drudis.2022.05.004_b0425","article-title":"Molecular properties of apelin: tissue distribution and receptor binding","volume":"1538","author":"Kawamata","year":"2001","journal-title":"BBA Mol Cell Res"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0430","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1210\/en.2004-0359","article-title":"Modification of the Terminal Residue of Apelin-13 Antagonizes Its Hypotensive Action","volume":"146","author":"Lee","year":"2005","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.drudis.2022.05.004_b0435","article-title":"The Role of Apelin\/APJ in a Mouse Model of Oxygen-induced Retinopathy","volume":"61","author":"Feng","year":"2020","journal-title":"Investig Ophthalmol Visual Sci"},{"issue":"1","key":"10.1016\/j.drudis.2022.05.004_b0440","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virol.2003.08.026","article-title":"The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity","volume":"317","author":"Zhou","year":"2003","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.drudis.2022.05.004_b0445","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1096\/fj.201601074R","article-title":"Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin","volume":"31","author":"Le Gonidec","year":"2017","journal-title":"Faseb J"},{"issue":"21","key":"10.1016\/j.drudis.2022.05.004_b0450","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1016\/j.bmcl.2012.08.105","article-title":"Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor","volume":"22","author":"Maloney","year":"2012","journal-title":"Bioorgan Med Chem Lett"},{"issue":"24","key":"10.1016\/j.drudis.2022.05.004_b0455","article-title":"[Effects of puerarin on expression of apelin and its receptor of 2K1C renal hypertension rats]","volume":"34","author":"Ge","year":"2009","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin Materia Medica"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0460","article-title":"[Effect of puerarin combined with felodipine on mRNA and protein expression of apelin and APJ in renovascular hypertensive rat]","volume":"38","author":"Zhen-Gui","year":"2013","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin Materia Medica"},{"issue":"9","key":"10.1016\/j.drudis.2022.05.004_b0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202436","article-title":"Repurposing antimalarial aminoquinolines and related compounds for treatment of retinal neovascularization","volume":"13","author":"McAnally","year":"2018","journal-title":"Plos One"},{"issue":"3","key":"10.1016\/j.drudis.2022.05.004_b0470","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1126\/sciadv.aax7379","article-title":"Structure-guided discovery of a single-domain antibody agonist against human apelin receptor","volume":"6","author":"Ma","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.drudis.2022.05.004_b0475","unstructured":"Lu S-C, Wang M. Apelin antigen-binding proteins and uses thereof. US9156911, 2015-10-13."},{"key":"10.1016\/j.drudis.2022.05.004_b0480","unstructured":"Stevis; Panayiotis; Gromada; Jesper; Murphy; J., A.; Ray; Yonaton; Kim; H., J.; Lobov; B., I. APLNR modulators and uses thereof. AU2014352962, 2019-11-07."},{"key":"10.1016\/j.drudis.2022.05.004_b0485","unstructured":"Penninger Josef, Uribesalgo. Iris Combination of an Apelin Antagonist and an Angiogenesis Inhibitor for the Treatment of Cancer. WO2017174758, 2017-10-12."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462200191X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462200191X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:02:44Z","timestamp":1761224564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462200191X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":97,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S135964462200191X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2022.05.004","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APJ\/apelin: A promising target for the treatment of retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}